WithdrawnPhase 3NCT01549847

A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Biolab Sanus Farmaceutica
Principal Investigator
Acary Souza Bulle Oliveira, MD, PhD
Federal University of São Paulo
Intervention
L-carnitine and piracetam(drug)
Eligibility
18-60 years · All sexes

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01549847 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis →

← Back to all trials